RAISE: Collecting Better Data II: System Infrastructure

Thursday, February 16, 2023

2-3 PM ET  


Incomplete and incWorkshop 3 themeonsistent capture of information about race and ethnicity in real-world data (RWD) limits a full understanding of the distribution, safety, and effectiveness of FDA-regulated products, which impacts the health of the public.

The Reagan-Udall Foundation for the FDA, in collaboration with FDA's Office of Minority Health and Health Equity, launched RAISE to elevate the capture and curation of race and ethnicity data in health care settings to ultimately improve the quality of health care and medical products. 

Read speaker bios 

Learn more about RAISE 

Read the Meeting Summary

Review all Meeting Summaries



        Speaker: Susan C. Winckler RPh, Esq, Reagan-Udall Foundation for the FDA

Welcome Remarks from FDA
        Speaker: RDML Richardae Araojo, PharmD, MS, U.S. Food and Drug Administration

Connecting the Dots: From Incentives and Framework to Infrastructure
        Speaker: Carla Rodriguez-Watson, PhD, MPH, Reagan-Udall Foundation for the FDA


       The Human at The Center: The Data They Generate, and The Goal of Health Equity                          
Meredith Welsh, SVP, Health Operations 
       SameSky Health 

        Reconciling Race and Enhancing Ethnicity: Challenges in Real-World Data (RWD)                          
Andrew Kress, Co-founder and CEO

Moderated Discussion 
         Moderator: Oscar Benavidez, MD, MBA, MPP 
         Managing Director/Chief Congenital Cardiology and DEI Director 
         Massachusetts General Hospital 


          Allen Hsiao MD, FAAP, FAMIA, Yale School of Medicine
          Carmela Couderc, Office of Technology, Office of  the National Coordinator
          for Health Information Technology              
          Meredith Welsh
          Andrew Kress


This project is supported by the Food and Drug Administration (FDA) Office of Minority Health and Health Equity of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award (FAIN) totaling $499,514 (100% funded by FDA OMHHE/HHS). The contents are those of the author(s) and do not necessarily represent the official views of nor an endorsement by FDA/HHS, or the U.S. Government.